Cargando…

Financial toxicity of cancer treatment in India: towards closing the cancer care gap

BACKGROUND: The rising economic burden of cancer on patients is an important determinant of access to treatment initiation and adherence in India. Several publicly financed health insurance (PFHI) schemes have been launched in India, with treatment for cancer as an explicit inclusion in the health b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prinja, Shankar, Dixit, Jyoti, Gupta, Nidhi, Dhankhar, Anushikha, Kataki, Amal Chandra, Roy, Partha Sarathi, Mehra, Nikita, Kumar, Lalit, Singh, Ashish, Malhotra, Pankaj, Goyal, Aarti, Rajsekar, Kavitha, Krishnamurthy, Manjunath Nookala, Gupta, Sudeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316647/ https://www.ncbi.nlm.nih.gov/pubmed/37404274 http://dx.doi.org/10.3389/fpubh.2023.1065737

Ejemplares similares

Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol
por: Prinja, Shankar, et al.
Publicado: (2021)

Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India
por: Gupta, Dharna, et al.
Publicado: (2023)

Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India—A Model-Based Economic Analysis
por: Gupta, Nidhi, et al.
Publicado: (2022)

Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India
por: Nehra, Prerika, et al.
Publicado: (2023)

Impact of India's publicly financed health insurance scheme on public sector district hospitals: a health financing perspective
por: Prinja, Shankar, et al.
Publicado: (2022)

Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment
por: Sharma, Deepshikha, et al.
Publicado: (2023)

Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India
por: Chugh, Yashika, et al.
Publicado: (2022)

National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India
por: Prinja, Shankar, et al.
Publicado: (2021)

Cost Effectiveness of Trastuzumab for Management of Breast Cancer in India
por: Gupta, Nidhi, et al.
Publicado: (2020)

Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol
por: Prinja, Shankar, et al.
Publicado: (2020)

Cost-Effectiveness of Temozolamide for Treatment of Glioblastoma Multiforme in India
por: Gupta, Nidhi, et al.
Publicado: (2021)

Out-of-Pocket, Catastrophic Health Expenditure and Distress Financing on Non-Communicable Diseases in India: A Systematic Review with Meta-Analysis
por: Dhankhar, Anushikha, et al.
Publicado: (2021)

Censoring in Clinical Trials: Review of Survival Analysis Techniques
por: Prinja, Shankar, et al.
Publicado: (2010)

Refining the provider payment system of India’s government-funded health insurance programme: an econometric analysis
por: Prinja, Shankar, et al.
Publicado: (2023)

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
por: Butani, Dimple, et al.
Publicado: (2021)

Correction: Viral Hepatitis as a Public Health Concern: A Narrative Review About the Current Scenario and the Way Forward
por: Bhadoria, Ajeet S, et al.
Publicado: (2022)

Viral Hepatitis as a Public Health Concern: A Narrative Review About the Current Scenario and the Way Forward
por: Bhadoria, Ajeet S, et al.
Publicado: (2022)

Cost of hemodialysis in a public sector tertiary hospital of India
por: Kaur, Gunjeet, et al.
Publicado: (2018)

Epidemiological profile of retinoblastoma in North India: Implications for primary care and family physicians
por: Gupta, Nidhi, et al.
Publicado: (2020)

Health related quality of life among Rheumatic Fever and Rheumatic Heart Disease patients in India
por: Dixit, Jyoti, et al.
Publicado: (2021)

Cost analysis of implementing mHealth intervention for maternal, newborn & child health care through community health workers: assessment of ReMIND program in Uttar Pradesh, India
por: Prinja, Shankar, et al.
Publicado: (2018)

Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer
por: Gota, Vikram, et al.
Publicado: (2021)

Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India
por: Gupta, Nidhi, et al.
Publicado: (2021)

Cost-effectiveness of Post-Mastectomy Radiotherapy (PMRT) for breast cancer in India: An economic modelling study
por: Gupta, Nidhi, et al.
Publicado: (2022)

Role of insurance in determining utilization of healthcare and financial risk protection in India
por: Prinja, Shankar, et al.
Publicado: (2019)

Cost effectiveness of mHealth intervention by community health workers for reducing maternal and newborn mortality in rural Uttar Pradesh, India
por: Prinja, Shankar, et al.
Publicado: (2018)

Protocol for estimating the willingness-to-pay-based value for a quality-adjusted life year to aid health technology assessment in India: a cross-sectional study
por: Chugh, Yashika, et al.
Publicado: (2023)

Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey
por: Krishnamurthy, Manjunath Nookala, et al.
Publicado: (2022)

Cost of Treatment of Valvular Heart Disease at a Tertiary Hospital in North India: Policy Implications
por: Prinja, Shankar, et al.
Publicado: (2019)

Effect of COVID-19 on Access to Cancer Care in India
por: Gupta, Nidhi, et al.
Publicado: (2021)

Health-related quality of life among Indian population: The EQ-5D population norms for India
por: Jyani, Gaurav, et al.
Publicado: (2023)

Impact assessment and cost-effectiveness of m-health application used by community health workers for maternal, newborn and child health care services in rural Uttar Pradesh, India: a study protocol
por: Prinja, Shankar, et al.
Publicado: (2016)

Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy
por: Sharma, Jyoti Bhagatram, et al.
Publicado: (2021)

Health technology assessment in India: Reflection & future roadmap
por: Prinja, Shankar, et al.
Publicado: (2020)

Coverage and Financial Risk Protection for Institutional Delivery: How Universal Is Provision of Maternal Health Care in India?
por: Prinja, Shankar, et al.
Publicado: (2015)

Incremental value of 68-gallium-prostate-specific membrane antigen positron emission tomography/computed tomography in patients with abnormal prostate-specific antigen and benign transrectal ultrasound biopsy
por: Gupta, Manoj, et al.
Publicado: (2018)

Metastasis in urothelial carcinoma mimicking prostate cancer metastasis in Ga-68 prostate-specific membrane antigen positron emission tomography-computed tomography in a case of synchronous malignancy
por: Gupta, Manoj, et al.
Publicado: (2016)

Cost of Delivering Health Care Services in Public Sector Primary and Community Health Centres in North India
por: Prinja, Shankar, et al.
Publicado: (2016)

Economic Analysis of Delivering Postpartum Intrauterine Contraceptive Device Services in India
por: Bahuguna, Pankaj, et al.
Publicado: (2019)

Validating the rigour of adaptive methods of economic evaluation
por: Chauhan, Akashdeep Singh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cpoqe6lkt7mj65iro5j90gsur6